Market News & Trends
ProJect Pharmaceutics Expands Facilities for Formulation & Lyophilization Process Development
ProJect Pharmaceutics(PJP), specialized in formulation and process development for parenteral drug products, announces that it has extended its safety facilities by laboratories dedicated to handle GMO S2 and BSL-2 based biological products such as live virus vaccines…
Fierce Competition Amongst Checkpoint Inhibitor Developers Ahead
Over the next ten years, PD-(L)1 inhibitors will continue to dominate the checkpoint modulators market, says leading data and analytics companyGlobalData.
Catalent Completes Multi-Million Expansion at Singapore Clinical Supply Facility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion of a two-year, $4.6 million…
SELLAS Life Sciences Group Announces Notice of Allowance From US PTO for New Patent Covering Composition of Matter for WT-1 Peptides
SELLAS Life Sciences Group, Inc. recently announced that the US PTO issued a Notice of Allowance for US Patent Application No. 14/760,997 related to certain…
Jupiter Orphan Therapeutics Announces IND Submission for Mucopolysaccharidosis Type-I
Jupiter Orphan Therapeutics, Inc. recently announced it had submitted its IND to the FDA on March 12, 2018 for Mucopolysaccharidosis Type-I (MPSI). This will be…
Ginolis Provides Mobidiag High Throughput Manufacturing Lines for Growing Needs of Novodiag Cartridges
Ginolis Ltd recently announced it has signed an agreement with Mobidiag Ltd, a Finnish molecular diagnostics for infectious diseases company. Through the implementation of cutting-edge…
Grand River Aseptic Manufacturing Continues to Expand Capabilities With New, State-of-the-Art Colanar Syringe Filler
Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract manufacturing organization, expands its capabilities in syringe filling at its FDA-inspected, cGMP-compliant manufacturing facility in…
Owlstone Medical Raises $15 Million to Drive Commercialization of Breath Biopsy Platform
Owlstone Medical Ltd recently announced that it has raised $15 million to drive the global commercialization of its Breath Biopsy platform. The funds will enable…
CDMO Pfizer CentreOne Launches Green-Chemistry Progesterone API
CDMO Pfizer CentreOne Launches Green-Chemistry Progesterone API Pfizer CentreOne recently announced the introduction of Enviero progesterone into the API marketplace. Enviero progesterone is produced by…
Majority of Clinical Trials Planned in 2018 Belong to Oncology
Cancer is one of the leading causes of morbidity and mortality across the world. Not surprisingly, oncology is going to be the top therapy area…
Enteris BioPharma Initiates Feasibility Program With Ferring Pharmaceuticals to Develop Oral Formulation of a Peptide
Enteris BioPharma, Inc. recently announced it has entered into a feasibility development agreement with Ferring Pharmaceuticals to utilize Enteris' proprietary oral delivery platform, Peptelligence, to…
International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Trial
International Stem Cell Corporation recently announced the eighth participant, which completes the dosing of the second cohort of the clinical trial for Parkinson's disease, was…
Evotec & Sanofi to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near…
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement With the University of Massachusetts Medical School
Fortress Biotech recently announced that its subsidiary, Aevitas Therapeutics, Inc. (Aevitas), has entered into a sponsored research agreement (SRA) with the laboratory of Guangping Gao,…
PCI Completes Acquisition of Australia-Based Pharmaceutical Packaging Professionals
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) recently announced the completion of its acquisition of Melbourne, Australia-based Pharmaceutical Packaging Professionals (PPP). PPP is…
Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial
Idera Pharmaceuticals, Inc. recently announced the start of a Phase 3 global, multi-center, open-label clinical trial to evaluate the efficacy and safety of intratumoral IMO-2125…
Galera Therapeutics Receives FDA Breakthrough Therapy Designation
Galera Therapeutics, Inc. recently announced that the US FDA has granted Breakthrough Therapy designation to lead candidate GC4419, a highly selective and potent small molecule…
Elligo Health Research & Saama Technologies Announce Strategic Partnership
Elligo Health Research is partnering withSaama Technologies, Inc. to improve awareness of, access to, and participation in clinical trials for US physicians and patients. “We…
CicloMed Announces First Patient Dosed With Ciclopirox Prodrug in Phase I Trial
CicloMed LLC recently announced that the first patient has been dosed in a Phase I clinical trial. The CPX-POM-001 study is characterizing the safety, dose…
BC Platforms Launches End-to-End Solution for Precision Medicine Powered by the Microsoft Genomics Service
BC Platforms, a pioneer in genomic data management and analytics, recently announced it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses…
